» Articles » PMID: 35448552

Early Effects of Metabolic Syndrome on ATP-Sensitive Potassium Channels from Rat Pancreatic Beta Cells

Overview
Journal Metabolites
Publisher MDPI
Date 2022 Apr 21
PMID 35448552
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome (MS) is a cluster of metabolic signs that increases the risk of developing type 2 two diabetes mellitus and cardiovascular diseases. MS leads to pancreatic beta cell exhaustion and decreased insulin secretion through unknown mechanisms in a time-dependent manner. ATP-sensitive potassium channels (K channels), common targets of anti-diabetic drugs, participate in the glucose-stimulated insulin secretion, coupling the metabolic status and electrical activity of pancreatic beta cells. We investigated the early effects of MS on the conductance, ATP and glybenclamide sensitivity of the K channels. We used rats fed with a high-sucrose diet (HSD) for 8 weeks as a MS model. In excised membrane patches, control and HSD channels showed similar unitary conductance and ATP sensitivity pancreatic beta cells in their K channels In contrast, MS produced variability in the sensitivity to glybenclamide of K channels. We observed two subpopulations of pancreatic beta cells, one with similar (Gly1) and one with increased (Gly2) glybenclamide sensitivity compared to the control group. This study shows that the early effects of MS produced by consuming high-sugar beverages can affect the pharmacological properties of K channels to one of the drugs used for diabetes treatment.

Citing Articles

The effects of sucrose and arsenic on muscular insulin signaling pathways differ between the gastrocnemius and quadriceps muscles.

Panico P, Velasco M, Salazar A, Ostrosky-Wegman P, Hiriart M Front Endocrinol (Lausanne). 2023; 14:1165415.

PMID: 37229459 PMC: 10205014. DOI: 10.3389/fendo.2023.1165415.


The reversible effects of free fatty acids on sulfonylurea-stimulated insulin secretion are related to the expression and dynamin-mediated endocytosis of KATP channels in pancreatic β cells.

Wei C, Zhang Z, Fu Q, He Y, Yang T, Sun M Endocr Connect. 2022; 12(1).

PMID: 36398885 PMC: 9782416. DOI: 10.1530/EC-22-0221.

References
1.
Grundy S, Neeland I, Turer A, Vega G . Ethnic and gender susceptibility to metabolic risk. Metab Syndr Relat Disord. 2013; 12(2):110-6. PMC: 3935470. DOI: 10.1089/met.2013.0113. View

2.
Velasco M, Diaz-Garcia C, Larque C, Hiriart M . Modulation of Ionic Channels and Insulin Secretion by Drugs and Hormones in Pancreatic Beta Cells. Mol Pharmacol. 2016; 90(3):341-57. DOI: 10.1124/mol.116.103861. View

3.
Hudish L, Reusch J, Sussel L . β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019; 129(10):4001-4008. PMC: 6763241. DOI: 10.1172/JCI129188. View

4.
Cerf M . Beta Cell Physiological Dynamics and Dysfunctional Transitions in Response to Islet Inflammation in Obesity and Diabetes. Metabolites. 2020; 10(11). PMC: 7697558. DOI: 10.3390/metabo10110452. View

5.
Baukrowitz T, Schulte U, Oliver D, Herlitze S, Krauter T, Tucker S . PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science. 1998; 282(5391):1141-4. DOI: 10.1126/science.282.5391.1141. View